We are live on ! Find out more
GRTS

Gritstone bio, Inc. Common Stock

Delisted

GRTS was delisted on the 21st of October, 2024.

56 hedge funds and large institutions have $20.7M invested in Gritstone bio, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 24 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more call options, than puts

Call options by funds: $252K | Put options by funds: $99K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

15% less capital invested

Capital invested by funds: $24.2M → $20.7M (-$3.58M)

29% less funds holding

Funds holding: 7956 (-23)

42% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 24

74% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 31

Holders
56
Holders Change
-23
Holders Change %
-29.11%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
8
Increased
14
Reduced
24
Closed
31
Calls
$252K
Puts
$99K
Net Calls
+$153K
Net Calls Change
-$744K

GRTS Hedge Fund Activity: Q3 2024 in Review

56 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q3 2024, worth a combined $20.7M — down 15% from $24.2M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of GRTS and 8 opened new positions — a net loss of 23 holders — while 24 trimmed existing stakes and 14 added.

The largest buyer was Morgan Stanley, adding an estimated $3.27M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $2.14M sold.

  • 56 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q3 2024, down from 79 in Q2 2024.
  • Funds reported $20.7M of Gritstone bio, Inc. Common Stock stock for Q3 2024, down 15% quarter-over-quarter.
  • 8 funds opened new Gritstone bio, Inc. Common Stock positions in Q3 2024 and 31 closed out, a net change of -23 holders.
  • The largest Gritstone bio, Inc. Common Stock buyer in Q3 2024 was Morgan Stanley, an estimated $3.27M added.
  • The largest Gritstone bio, Inc. Common Stock seller in Q3 2024 was Alyeska Investment Group, an estimated $2.14M sold.

Based on aggregated 13F filings for Q3 2024.